Constitutive MAPK pathway activation is very common in thyroid cancers and is involved in RAI refractoriness by suppressing the expression of genes that regulate iodide uptake, thyroid hormone synthesis, and differentiation, such as NIS, TPO, TG, and PAX8 [5, 6]. This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.